Working… Menu

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03734913
Recruitment Status : Recruiting
First Posted : November 8, 2018
Last Update Posted : July 22, 2020
Information provided by (Responsible Party):
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 31, 2021
Estimated Study Completion Date : July 31, 2021